Lunai Bioworks Inc
NASDAQ:LNAI
Lunai Bioworks Inc
NASDAQ:LNAI
Price:
0.81
USD
-23.58%
Market Closed
Market Cap:
$19m
Balance Sheet
Balance Sheet Decomposition
Lunai Bioworks Inc
Lunai Bioworks Inc
Balance Sheet Decomposition is not available for
Lunai Bioworks Inc
Lunai Bioworks Inc
Balance Sheet
Lunai Bioworks Inc
Lunai Bioworks Inc
Currency: USD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
4
|
16
|
12
|
9
|
21
|
9
|
2
|
0
|
0
|
|
| Cash |
0
|
0
|
4
|
16
|
12
|
9
|
21
|
9
|
2
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
1
|
4
|
16
|
13
|
9
|
21
|
10
|
3
|
2
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
3
|
2
|
2
|
1
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
3
|
2
|
2
|
1
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
155
|
155
|
155
|
155
|
62
|
43
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
12
|
12
|
12
|
12
|
12
|
12
|
159
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
12
|
12
|
12
|
12
|
12
|
12
|
159
|
6
|
|
| Total Assets |
2
N/A
|
1
-57%
|
5
+400%
|
183
+3 956%
|
180
-1%
|
178
-1%
|
190
+6%
|
85
-55%
|
58
-31%
|
163
+180%
|
8
-95%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
5
|
9
|
13
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
6
|
6
|
|
| Short-Term Debt |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
5
|
2
|
6
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
13
|
1
|
|
| Total Current Liabilities |
1
|
2
|
3
|
1
|
1
|
1
|
2
|
7
|
11
|
30
|
29
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
6
|
6
|
5
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
23
|
6
|
5
|
7
|
1
|
1
|
1
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+50%
|
3
+100%
|
24
+693%
|
7
-71%
|
12
+74%
|
15
+26%
|
12
-19%
|
12
-2%
|
31
+164%
|
30
-5%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
26
|
29
|
35
|
53
|
64
|
91
|
204
|
244
|
325
|
510
|
|
| Additional Paid In Capital |
25
|
25
|
30
|
193
|
226
|
231
|
266
|
277
|
291
|
457
|
478
|
|
| Other Equity |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
|
| Total Equity |
1
N/A
|
1
N/A
|
2
N/A
|
159
+10 480%
|
173
+9%
|
166
-4%
|
175
+5%
|
73
-58%
|
47
-36%
|
132
+184%
|
21
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-57%
|
5
+400%
|
183
+3 956%
|
180
-1%
|
178
-1%
|
190
+6%
|
85
-55%
|
58
-31%
|
163
+180%
|
8
-95%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
4
|
5
|
5
|
5
|
5
|
6
|
16
|
18
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
